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Abstract 
 
Basal cells are stem/progenitor cells that maintain airway homeostasis, enact repair 
following epithelial injury and are a candidate cell-of-origin for lung squamous cell 
carcinoma (LUSC). Heterogeneity of basal cells is recognized in terms of gene 
expression and differentiation capacity. In this Issue, Pagano and colleagues isolate 
a subset of immortalized basal cells that are characterized by high motility, 
suggesting that they might also be heterogeneous in their biophysical properties. 
Motility-selected cells displayed an increased ability to colonize the lung in vivo. The 
possible implications of these findings are discussed in terms of basal cell 
heterogeneity, epithelial cell migration and modelling of metastasis that occurs early 
in cancer evolution. 
 
 
Background 
 
The human upper airway epithelium is a pseudostratified barrier that protects the 
lungs from infection and inhaled particulate matter using the mucociliary escalator. 
Broadly, this function is supported by three major cell types: mucosecretory cells, 
ciliated cells and basal progenitor cells that function to regenerate the differentiated 
luminal populations [1]. Malignant transformation of this epithelium leads to lung 
squamous cell carcinoma (LUSC), which accounts for approximately 35% of non-
small cell lung cancers, occurs predominantly in the central airways and has a poor 
prognosis. LUSC tumors are thought to arise through a step-wise epithelial 
transformation involving squamous metaplasia, dysplasia and carcinoma-in-situ 
(CIS) before progression to invasive cancer. Increasingly, it is recognized that 
significant genetic diversity, the basis of tumor evolution, exists in these pre-
malignant disease stages and even in normal epithelia. It is noteworthy that in LUSC 
not all pre-invasive lesions inevitably progress to malignancy and the genetic, 
cellular and epigenetic basis of these changes are areas of active investigation [2]. 
Ultimately, metastases - tumors derived from the primary tumor found in regional 
lymph nodes and distant organs - are the predominant cause of mortality among 
LUSC patients but, despite forming part of the late-stage clinical presentation of the 
disease, it remains unclear how and at what stage metastatic seeding occurs. 
Importantly, recent discoveries in other cancer types suggest that metastases can 
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evolve in parallel with the primary tumor from an early stage of the disease course 
[3]. 
 
How the cellular context in which mutations arise influences LUSC progression is not 
currently well understood but airway basal stem cells are the leading cell-of-origin 
candidate. These cells represent the major proliferative airway epithelial cell type, 
share expression of basal cell markers such as keratin 5 (KRT5) with LUSC tumors 
and can give rise to LUSC-like tumors in genetically engineered mouse models 
(GEMMs). In the current issue, Pagano and colleagues describe a novel approach to 
isolate a subpopulation of immortalized human basal cells that are highly motile in 
culture by sequential selection of cells capable of migration through micrometer-
scale transwell inserts [4]. The motility phenotype is cell intrinsic, RAC1-dependent 
and can be exaggerated by overexpression of Snail. Through microarray analysis 
the authors identify a gene expression signature associated with increased motility in 
which many genes are also associated with poor outcome in LUSC. Further, motility-
selected cells demonstrated enhanced lung colonization after intravenous injection in 
mice, suggesting the possible relevance of a motile phenotype to micrometastatic 
seeding. The development of a platform to isolate more motile cells from 
heterogeneous basal cell populations in a step-wise manner has potential 
implications for airway basal cell heterogeneity, airway epithelial cell migration and 
modelling metastatic seeding during early LUSC. 
 
Airway Basal Cell Heterogeneity 
 
Airway basal cells have long been thought to be a heterogeneous population of cells. 
Early data separated distinct populations of basal cells and ‘intermediate’ cells based 
on morphological properties such as the proximity of nuclei to the basement 
membrane and basal cells also exhibit differences in marker gene expression; for 
example, only a subset of KRT5+ basal cells express the transcription factor P63 or 
the injury-induced protein KRT14. More recent studies support the functional 
importance of these basal cell subsets in regard to differentiation. During 
homeostasis, parabasal ‘intermediate’ cells express markers of both basal and 
luminal cells (KRT5+P63-KRT8+) and are thought to represent differentiating cells. 
Indeed, in the murine trachea, Notch3 activation is a hallmark of parabasal cells that 
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can then respond to Notch1/2 signaling to be become secretory precursors and 
ultimately mature ciliated or mucosecretory cells [5, 6]. Interestingly, Notch3 is 
expressed by human parabasal cells and is downregulated in areas of squamous 
metaplasia, suggesting that aberrant differentiation of parabasal cells might be 
relevant in pre-invasive lesion formation [6]. In injury models, further heterogeneity 
has been described among P63+ basal cells as these rapidly become dual-positive 
for P63 and either MYB or Notch2 intracellular domain (N2ICD) and these cells only 
give rise to ciliated or mucosecretory cells, respectively [7]. As such, different basal 
cell lineage trajectories might be relevant to homeostasis and injury repair.  
However, despite these findings, little is known about basal cell heterogeneity 
assessed by measures other than differentiation capacity. As such, the suggestion 
that a subset of premalignant basal cells might be intrinsically migratory in nature is 
an exciting hypothesis.  
 
Epithelial Cell Motility and Lung Cancer 
 
That the motility phenotype described by Pagano et al. is cell intrinsic, i.e. retained 
over serial cultivation, is suggestive of a relevance to in vivo basal cell heterogeneity 
and airway cell migration but care must be taken in extrapolating these results due to 
the possibility of changes introduced by cell culture. Basal cells were immortalized 
using retroviruses carrying Cdk4 and hTERT [8] and it remains to be determined 
whether this migratory subset is present in primary human basal cells prior to 
immortalization. Although the protocol avoids the use of viral oncogenes, these 
immortalized cells still contain structural genomic rearrangements that could 
theoretically influence cellular behavior. Beyond this, many important questions are 
raised. Firstly, what is the basis of heritability of the motility phenotype? Although 
highly motile cells are found in all three donor lines investigated, the authors find 
important differences between these, suggesting that multiple mechanisms to 
achieve similar phenotypes might exist. Moreover, does such a motile basal cell 
subpopulation exist in vivo? And what proportion of cells are motile? Previous 
lineage tracing of homeostatic airways has suggested low levels of lateral motility of 
epithelial cells but low frequency, highly motile cells might be missed in such assays 
and frequently clonal relationships cannot be proven conclusively. In one human 
patient, spatially distinct pre-invasive CIS lesions appeared to be clonally related 
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based on a common, rare P53 mutation [9], so further studies to delineate the 
relationship between epithelial cell migration and field carcinogenesis are warranted.  
 
Pre-clinical studies of metastasis tend to focus on very late stage disease by using 
cell lines with high mutational burden and extensive genomic rearrangement but 
recent evidence has called into question the hypotheses that individual cells from the 
primary tumor seed metastases and that seeding of metastases occurs only during 
the late stages of tumor evolution. As such, novel strategies such as those described 
by Pagano et al. to investigate early micrometastatic seeding in LUSC are welcome. 
The authors demonstrate that dual TP53/KRAS-mutant immortalized basal cells do 
not survive long term in the lungs following intravenous injection in mice. However, 
the same cells were able to survive in the lungs following motility selection, 
suggesting that they are better suited for lung colonization. The basis of this is an 
important open question as gene expression data suggest that motility-selected cells 
are not undergoing epithelial-mesenchymal transition (EMT). The authors show that 
their motility-based selection does not favor cells with small size, small nuclei or high 
deformability but future studies on the nuclear integrity of motility-selected cells will 
be of interest. Nuclear rupture leading to DNA damage occurs during migration of 
cancer cells through pores of 5-20 µm [10] so aberrations sustained during migration 
- rather than motility itself – could potentially lead to selection of cells with enhanced 
colonization potential. While the current study employs KRAS-mutant cells, these 
mutations are rarely seen in the LUSC patient population so extension of this 
protocol into cell lines with P53 mutations in combination with other early events in 
the progression of lung squamous carcinogenesis might be very informative. 
 
Modelling Pre-Invasive Lung Squamous Cell Carcinoma 
 
Overall, the lack of available model systems to study pre-invasive LUSC is a major 
limitation for the field: tumors from GEMMs typically do not share comparable 
mutation profiles with human disease and do not recapitulate the progressive nature 
of human lesions. A recent study investigated the role of SOX2 - a transcription 
factor located on chromosome 3q, which is amplified prior to LUSC invasion - in 
early LUSC using the same immortalized cell lines as those used by Pagano et al. 
[11]. Combined P53 knockdown and SOX2 overexpression lead to dysplastic 
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transformation of organotypic cultures. In combination, these studies demonstrate 
significant recent progress in modelling key aspects of pre-invasive disease. To our 
knowledge, primary cell culture methods for expansion of CIS cells have yet to be 
described and so studies that manipulate immortalized normal airway basal cells to 
provide a platform amenable to testing much needed therapeutics for early 
intervention LUSC studies are a welcome advance. 
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